(Q34589479)

3 August 2017

title

Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence (English)

1 reference

3 August 2017

0 references

Amine Benyamina

1

1 reference

3 August 2017

Marie Lecacheux

2

1 reference

3 August 2017

Lisa Blecha

3

1 reference

3 August 2017

Michel Reynaud

4

1 reference

3 August 2017

Michael Lukasiewcz

5

1 reference

3 August 2017

publication date

1 March 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

479-491

1 reference

Epidemiology of substance use in adolescence: prevalence, trends and policy implications

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Review of the validity and significance of cannabis withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Causal association between cannabis and psychosis: examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The environment and schizophrenia: the role of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Treatment of marijuana dependence: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Bupropion SR worsens mood during marijuana withdrawal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Effects of oral THC maintenance on smoked marijuana self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Buspirone for treatment of marijuana dependence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Comparison of extended versus brief treatments for marijuana use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Brief treatments for cannabis dependence: findings from a randomized multisite trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Abstinence rates following behavioral treatments for marijuana dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The Marijuana Check-up: promoting change in ambivalent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Substance Abuse Treatment Characteristics of Probation‐Referred Young Adults in a Community‐Based Outpatient Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Motivational enhancement therapy for adolescent marijuana users: a preliminary randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Cannabis treatment outcomes among legally coerced and non-coerced adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Absence of iatrogenic or contagion effects in adolescent group therapy: findings from the Cannabis Youth Treatment (CYT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

The cost-effectiveness of four treatments for marijuana dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Patterns, predictors and impact of substance use in early psychosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.3.479

21 January 2018

Identifiers

DOI

10.1586/14737175.8.3.479

1 reference

3 August 2017

1 reference